Physician profile
Samar D Kubba
NPI 1871831024
$1,593.94
in general payments reported to CMS, 2019-2025
7 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $119 · 2021: $336 · 2023: $332 · 2024: $194 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $507.39 | 2019-2023 | Xarelto |
| Edwards Lifesciences Corporation | $389.41 | 2023-2025 | Sapien 3 Ultra Resilia |
| Inari Medical, INC. | $194.01 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kestra Medical Technology Services, INC. | $169.95 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $116.46 | 2019 | |
| Abbvie INC. | $114.49 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $102.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samar Kubba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.